Parallel Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.34M | Sell |
5,266
-184
| -3% | -$81.9K | 0.05% | 243 |
|
|
2025
Q1 | $2.64M | Sell |
5,450
-1,885
| -26% | -$914K | 0.06% | 209 |
|
|
2024
Q4 | $2.95M | Buy |
7,335
+143
| +2% | +$57.6K | 0.07% | 201 |
|
|
2024
Q3 | $3.34M | Buy |
7,192
+820
| +13% | +$381K | 0.08% | 189 |
|
|
2024
Q2 | $2.99M | Buy |
6,372
+863
| +16% | +$404K | 0.08% | 189 |
|
|
2024
Q1 | $2.3M | Buy |
5,509
+733
| +15% | +$306K | 0.06% | 210 |
|
|
2023
Q4 | $1.94M | Buy |
4,776
+1,309
| +38% | +$533K | 0.06% | 208 |
|
|
2023
Q3 | $1.21M | Buy |
3,467
+242
| +8% | +$84.2K | 0.04% | 280 |
|
|
2023
Q2 | $1.13M | Buy |
3,225
+177
| +6% | +$62.3K | 0.04% | 298 |
|
|
2023
Q1 | $960K | Buy |
3,048
+843
| +38% | +$266K | 0.03% | 319 |
|
|
2022
Q4 | $637K | Buy |
2,205
+22
| +1% | +$6.35K | 0.03% | 347 |
|
|
2022
Q3 | $632K | Buy |
2,183
+159
| +8% | +$46K | 0.03% | 333 |
|
|
2022
Q2 | $570K | Buy |
2,024
+71
| +4% | +$20K | 0.03% | 359 |
|
|
2022
Q1 | $501K | Buy |
1,953
+101
| +5% | +$25.9K | 0.02% | 428 |
|
|
2021
Q4 | $407K | Buy |
1,852
+400
| +28% | +$87.9K | 0.02% | 511 |
|
|
2021
Q3 | $263K | Buy |
1,452
+115
| +9% | +$20.8K | 0.01% | 609 |
|
|
2021
Q2 | $270K | Buy |
1,337
+69
| +5% | +$13.9K | 0.01% | 565 |
|
|
2021
Q1 | $272K | Buy |
1,268
+22
| +2% | +$4.72K | 0.01% | 532 |
|
|
2020
Q4 | $294K | Sell |
1,246
-131
| -10% | -$30.9K | 0.02% | 466 |
|
|
2020
Q3 | $375K | Sell |
1,377
-55
| -4% | -$15K | 0.02% | 370 |
|
|
2020
Q2 | $415K | Buy |
1,432
+156
| +12% | +$45.2K | 0.03% | 336 |
|
|
2020
Q1 | $303K | Buy |
1,276
+149
| +13% | +$35.4K | 0.02% | 349 |
|
|
2019
Q4 | $247K | Buy |
1,127
+48
| +4% | +$10.5K | 0.02% | 434 |
|
|
2019
Q3 | $183K | Buy |
1,079
+143
| +15% | +$24.3K | 0.02% | 496 |
|
|
2019
Q2 | $172K | Sell |
936
-63
| -6% | -$11.6K | 0.02% | 476 |
|
|
2019
Q1 | $184K | Sell |
999
-92
| -8% | -$16.9K | 0.02% | 430 |
|
|
2018
Q4 | $180K | Buy |
1,091
+60
| +6% | +$9.9K | 0.03% | 381 |
|
|
2018
Q3 | $199K | Buy |
1,031
+10
| +1% | +$1.93K | 0.02% | 382 |
|
|
2018
Q2 | $173K | Buy |
1,021
+178
| +21% | +$30.2K | 0.02% | 391 |
|
|
2018
Q1 | $137K | Buy |
843
+29
| +4% | +$4.71K | 0.02% | 413 |
|
|
2017
Q4 | $122K | Sell |
814
-16
| -2% | -$2.4K | 0.02% | 431 |
|
|
2017
Q3 | $123K | Buy |
830
+63
| +8% | +$9.34K | 0.02% | 426 |
|
|
2017
Q2 | $116K | Sell |
767
-4
| -0.5% | -$605 | 0.02% | 435 |
|
|
2017
Q1 | $92K | Buy |
771
+177
| +30% | +$21.1K | 0.02% | 475 |
|
|
2016
Q4 | $44K | Buy |
+594
| New | +$44K | 0.01% | 629 |
|